Lessons learned: use of 24-hour ambulatory esophageal and gastric pH monitoring and its implications for proton pump inhibitor use in cancer patients requiring oral oncologic therapies
{{output}}
The proton pump inhibitors are widely prescribed for the symptomatic treatment of chronic epigastric pain and heartburn in cancer patients, but they carry the potential for drug-drug interactions (DDI) with oral antineoplastic agents. In this retrospective coh... ...
